|
⚲
|
| Keyboard |
| Accelmed Partners LP
✚
|
|
|---|---|
| CIK # | 0001662817 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001662817] | |
| 4 | [0001662817] | |
| D | [0001662817] | |
| SC 13D | [0001662817] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Accelmed Growth Partners LP | Strata Skin Sciences Inc | [2018-04-03] |
| Accelmed Growth Partners LP | Cogentix Medical Inc /DE/ | [2016-11-09] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Accelmed Growth Partners AGP Ltd | |
| Accelmed Partners GP LP | |
| Accelmed Partners LP | |
| Accelmed Growth Partners Management Ltd | |
| MELA Sciences Inc /NY | |
| Cogentix Medical Inc /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MELA Sciences Inc /NY SSKN
Common Stock
|
2024-07-15 | Buy | 230,573 | $3.14 | 723,999 |
|
MELA Sciences Inc /NY SSKN
Common Stock, $0.001 par value per share
|
2018-06-15 | Other | 75,590 | $1.09 | 82,393 |
|
MELA Sciences Inc /NY SSKN
Common Stock, $0.001 par value per share
|
2018-06-15 | Other | 75,590 | $1.09 | 82,393 |
|
MELA Sciences Inc /NY SSKN
Common Stock, $0.001 par value per share
|
2018-06-15 | Other | 75,590 | $1.09 | 82,393 |
|
MELA Sciences Inc /NY SSKN
Common Stock, $0.001 par value per share
|
2018-06-15 | Other | 75,590 | $1.09 | 82,393 |
|
Cogentix Medical Inc /DE/ CGNT
Common Stock, $0.01 par value per share
|
2018-04-20 | Tender | 16,129,033 | $3.85 | 62,096,777 |